Kroger (KR) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now — Positive

KR   Zacks Investment Research — September 02, 2025

Kroger (KR) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.

image for news Kroger (KR) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now

The consensus price target hints at an 114.1% upside potential for Bright Minds Biosciences Inc. (DRUG). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

image for news Does Bright Minds Biosciences Inc. (DRUG) Have the Potential to Rally 114.07% as Wall Street Analysts Expect?

The average of price targets set by Wall Street analysts indicates a potential upside of 173% in Edgewise Therapeutics (EWTX). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

image for news Wall Street Analysts Believe Edgewise Therapeutics (EWTX) Could Rally 172.96%: Here's is How to Trade

Can SiriusPoint (SPNT) Climb 33.55% to Reach the Level Wall Street Analysts Expect? — Positive

SPNT   Zacks Investment Research — September 02, 2025

The consensus price target hints at a 33.6% upside potential for SiriusPoint (SPNT). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

image for news Can SiriusPoint (SPNT) Climb 33.55% to Reach the Level Wall Street Analysts Expect?

Should You Buy Citizens Community Bancorp, Inc. (CZWI) After Golden Cross? — Positive

CZWI   Zacks Investment Research — September 02, 2025

Citizens Community Bancorp, Inc. (CZWI) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, CZWI's 50-day simple moving average broke out above its 200-day moving average; this is known as a "golden cross.

image for news Should You Buy Citizens Community Bancorp, Inc. (CZWI) After Golden Cross?

Wall Street Analysts See a 31.74% Upside in Integer (ITGR): Can the Stock Really Move This High? — Positive

ITGR   Zacks Investment Research — September 02, 2025

The mean of analysts' price targets for Integer (ITGR) points to a 31.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

image for news Wall Street Analysts See a 31.74% Upside in Integer (ITGR): Can the Stock Really Move This High?

Does Methanex (MEOH) Have the Potential to Rally 32.08% as Wall Street Analysts Expect? — Positive

MEOH   Zacks Investment Research — September 02, 2025

The consensus price target hints at a 32.1% upside potential for Methanex (MEOH). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

image for news Does Methanex (MEOH) Have the Potential to Rally 32.08% as Wall Street Analysts Expect?

American Axle & Manufacturing (AXL) Just Flashed Golden Cross Signal: Do You Buy? — Positive

AXL   Zacks Investment Research — September 02, 2025

From a technical perspective, American Axle & Manufacturing Holdings, Inc. (AXL) is looking like an interesting pick, as it just reached a key level of support. AXL's 50-day simple moving average crossed above its 200-day simple moving average, which is known as a "golden cross" in the trading world.

image for news American Axle & Manufacturing (AXL) Just Flashed Golden Cross Signal: Do You Buy?

Vitesse Energy (VTS) Just Flashed Golden Cross Signal: Do You Buy? — Positive

VTS   Zacks Investment Research — September 02, 2025

After reaching an important support level, Vitesse Energy, Inc. (VTS) could be a good stock pick from a technical perspective. VTS recently experienced a "golden cross" event, which saw its 50-day simple moving average breaking out above its 200-day simple moving average.

image for news Vitesse Energy (VTS) Just Flashed Golden Cross Signal: Do You Buy?

DuPont de Nemours (DD) Just Flashed Golden Cross Signal: Do You Buy? — Positive

DD   Zacks Investment Research — September 02, 2025

DuPont de Nemours, Inc. (DD) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, DD's 50-day simple moving average crossed above its 200-day simple moving average, known as a "golden cross.

image for news DuPont de Nemours (DD) Just Flashed Golden Cross Signal: Do You Buy?

Bigbear.ai: Will BBAI Stock Rebound To $10? — Negative

BBAI   Forbes — September 02, 2025

BigBear.ai (NYSE: BBAI), an AI solutions provider focused on national security, has dropped nearly 30% over the past month to $5. Despite this pullback, the stock still trades at a stretched nine times trailing revenue—well above its historical average of three times.

image for news Bigbear.ai: Will BBAI Stock Rebound To $10?

H World Group: Solid Execution Gives Confidence In Earnings Growth Outlook — Positive

HTHT   Seeking Alpha — September 02, 2025

I maintain my buy rating on HTHT, driven by strong asset-light expansion and deepening member engagement, fueling durable earnings growth. HTHT's rapid hotel pipeline conversion, cost-efficient build-outs, and growing membership engagement create a powerful growth flywheel and competitive moat. Early signs of RevPAR recovery in China and margin tailwinds from lower build costs further de-risk HTHT's growth outlook.

image for news H World Group: Solid Execution Gives Confidence In Earnings Growth Outlook

GSK Adds Around $5B in a Month: Here's How to Play the Stock — Neutral

GSK   Zacks Investment Research — September 02, 2025

GSK stock adds nearly $5B in value in a month as Specialty Medicines growth, pipeline wins and a strong outlook outweigh vaccine headwinds.

image for news GSK Adds Around $5B in a Month: Here's How to Play the Stock

New Costco hours take effect: What it means for members — Positive

COST   Fox Business — September 02, 2025

The retail giant's new "Executive Member Shopping Hours" policy gives top-tier premium subscribers private shopping time before stores open to other members.

image for news New Costco hours take effect: What it means for members

Is Broadcom a Buy Before Sept. 4 Earnings? — Positive

AVGO   24/7 Wall Street — September 02, 2025

Key Points Broadcom's (AVGO) 120% surge from April lows and 500% growth over three years stem from its AI chip dominance and VMware acquisition.

image for news Is Broadcom a Buy Before Sept. 4 Earnings?

Netflix's Strategic Bet on Asia: Will BIFF Tie-Up Strengthen Its Lead? — Positive

NFLX   Zacks Investment Research — September 02, 2025

NFLX deepens its Asia push with $2.5B for Korean content, $18B for India and a BIFF tie-up to fuel local storytelling and growth.

image for news Netflix's Strategic Bet on Asia: Will BIFF Tie-Up Strengthen Its Lead?

Best Growth Stocks to Buy for September 2nd — Positive

MEG  WDC  ZWS   Zacks Investment Research — September 02, 2025

Here are three stocks with buy ranks and strong growth characteristics for investors to consider today September 2nd:

image for news Best Growth Stocks to Buy for September 2nd

MUFG Announces $75 Million Financing for EarnIn — Neutral

MUFG   PRNewsWire — September 02, 2025

The senior secured revolving facility, with MUFG as Sole Lender, will fuel EarnIn's growth and expansion into innovative products, including Live Pay. NEW YORK , Sept.

image for news MUFG Announces $75 Million Financing for EarnIn

Curis to Present at Upcoming Healthcare Conferences in September — Neutral

CRIS   PRNewsWire — September 02, 2025

LEXINGTON, Mass. , Sept. 2, 2025 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 inhibitor, today announced that James Dentzer, President and Chief Executive Officer of Curis, will participate at the following conferences: The Cantor Global Healthcare Conference 2025 being held September 3 – 5, 2025.

image for news Curis to Present at Upcoming Healthcare Conferences in September

REIT Fundamentals Boost Case for This ETF — Positive

REIT   ETF Trends — September 02, 2025

The Federal Reserve hasn't delivered interest rate cuts to this point in 2025. So, widely followed real estate indexes and related ETFs haven't done much worth writing home about this year.

image for news REIT Fundamentals Boost Case for This ETF